{"id":6306,"date":"2026-03-25T07:08:13","date_gmt":"2026-03-25T06:08:13","guid":{"rendered":"https:\/\/cnatm.de\/?p=6306"},"modified":"2026-03-25T07:09:43","modified_gmt":"2026-03-25T06:09:43","slug":"great-news-for-cnatm","status":"publish","type":"post","link":"https:\/\/cnatm.de\/en\/great-news-for-cnatm\/","title":{"rendered":"Great News for CNATM!"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"6306\" class=\"elementor elementor-6306\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6363f8b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6363f8b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-807a88d\" data-id=\"807a88d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0b60e27 elementor-widget elementor-widget-heading\" data-id=\"0b60e27\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">2. Funding period for CNATM <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d33096d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d33096d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-35ba973\" data-id=\"35ba973\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9f642c9 elementor-widget elementor-widget-image\" data-id=\"9f642c9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"871\" src=\"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-1024x871.png\" class=\"attachment-large size-large wp-image-6307\" alt=\"\" srcset=\"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-1024x871.png 1024w, https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-300x255.png 300w, https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-768x653.png 768w, https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-1536x1306.png 1536w, https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-2048x1742.png 2048w, https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-14x12.png 14w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-478b506 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"478b506\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2625714\" data-id=\"2625714\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e5c8ce5 elementor-widget elementor-widget-spacer\" data-id=\"e5c8ce5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5c03aad elementor-widget elementor-widget-text-editor\" data-id=\"5c03aad\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"break-words          tvm-parent-container\"><span dir=\"ltr\">After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM has now been officially approved for its second funding period (2026-2029). CNATM continues to be the only national BMFTR cluster focused on nucleic acid therapeutics.<br \/><br \/>We are grateful for the continued support from BMFTR and look forward to continuing our projects over the next three years \u2014 with the goal of further strengthening Munich as an international hub for nucleic\u2011acid\u2011based research. <br \/><br \/>This marks a strong signal for innovation and the medicine of the future.<br \/>A heartfelt thank\u2011you goes to our\u00a0partners from the first funding phase\u00a0and to all\u00a0new partners joining us in the second phase. <br \/><br \/><\/span><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-597dc69 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"597dc69\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d07c590\" data-id=\"d07c590\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-77a75b2 elementor-widget elementor-widget-spacer\" data-id=\"77a75b2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Thomas Carell h\u00e4lt Vortrag beim Novo Nordisk Symposium &#8222;Frontiers in Biophysics and Chemical Biology&#8220;<\/p>","protected":false},"author":11,"featured_media":6307,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-6306","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Great News for CNATM! - CNATM<\/title>\n<meta name=\"description\" content=\"After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM (Cluster for Nucleic Acid Therapeutics Munich) has now been officially approved for its second funding period (2026-2029).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnatm.de\/en\/great-news-for-cnatm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Great News for CNATM! - CNATM\" \/>\n<meta property=\"og:description\" content=\"After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM (Cluster for Nucleic Acid Therapeutics Munich) has now been officially approved for its second funding period (2026-2029).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnatm.de\/en\/great-news-for-cnatm\/\" \/>\n<meta property=\"og:site_name\" content=\"CNATM\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-25T06:08:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-25T06:09:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-1024x871.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"871\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Patrizia Torelli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrizia Torelli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/\"},\"author\":{\"name\":\"Patrizia Torelli\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/#\\\/schema\\\/person\\\/f2fc8eccad93916c1b891b5fef1ac19e\"},\"headline\":\"Great News for CNATM!\",\"datePublished\":\"2026-03-25T06:08:13+00:00\",\"dateModified\":\"2026-03-25T06:09:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/\"},\"wordCount\":124,\"publisher\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cnatm.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Posting_Weiterfoerderung.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/\",\"url\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/\",\"name\":\"Great News for CNATM! - CNATM\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cnatm.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Posting_Weiterfoerderung.png\",\"datePublished\":\"2026-03-25T06:08:13+00:00\",\"dateModified\":\"2026-03-25T06:09:43+00:00\",\"description\":\"After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM (Cluster for Nucleic Acid Therapeutics Munich) has now been officially approved for its second funding period (2026-2029).\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/great-news-for-cnatm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cnatm.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Posting_Weiterfoerderung.png\",\"contentUrl\":\"https:\\\/\\\/cnatm.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Posting_Weiterfoerderung.png\",\"width\":2053,\"height\":1746},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/#website\",\"url\":\"https:\\\/\\\/cnatm.de\\\/\",\"name\":\"CNATM\",\"description\":\"Cluster for Nucleic Acid Therapeutics Munich\",\"publisher\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cnatm.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/#organization\",\"name\":\"CNATM\",\"url\":\"https:\\\/\\\/cnatm.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cnatm.de\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"contentUrl\":\"https:\\\/\\\/cnatm.de\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"width\":2362,\"height\":479,\"caption\":\"CNATM\"},\"image\":{\"@id\":\"https:\\\/\\\/cnatm.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cnatm.de\\\/#\\\/schema\\\/person\\\/f2fc8eccad93916c1b891b5fef1ac19e\",\"name\":\"Patrizia Torelli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"caption\":\"Patrizia Torelli\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Great News for CNATM! - CNATM","description":"After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM (Cluster for Nucleic Acid Therapeutics Munich) has now been officially approved for its second funding period (2026-2029).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnatm.de\/en\/great-news-for-cnatm\/","og_locale":"en_US","og_type":"article","og_title":"Great News for CNATM! - CNATM","og_description":"After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM (Cluster for Nucleic Acid Therapeutics Munich) has now been officially approved for its second funding period (2026-2029).","og_url":"https:\/\/cnatm.de\/en\/great-news-for-cnatm\/","og_site_name":"CNATM","article_published_time":"2026-03-25T06:08:13+00:00","article_modified_time":"2026-03-25T06:09:43+00:00","og_image":[{"width":1024,"height":871,"url":"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung-1024x871.png","type":"image\/png"}],"author":"Patrizia Torelli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrizia Torelli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/#article","isPartOf":{"@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/"},"author":{"name":"Patrizia Torelli","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e"},"headline":"Great News for CNATM!","datePublished":"2026-03-25T06:08:13+00:00","dateModified":"2026-03-25T06:09:43+00:00","mainEntityOfPage":{"@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/"},"wordCount":124,"publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"image":{"@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/","url":"https:\/\/cnatm.de\/great-news-for-cnatm\/","name":"Great News for CNATM! - CNATM","isPartOf":{"@id":"https:\/\/cnatm.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/#primaryimage"},"image":{"@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung.png","datePublished":"2026-03-25T06:08:13+00:00","dateModified":"2026-03-25T06:09:43+00:00","description":"After a positive evaluation by the reviewers and the jury, we are delighted to announce that CNATM (Cluster for Nucleic Acid Therapeutics Munich) has now been officially approved for its second funding period (2026-2029).","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnatm.de\/great-news-for-cnatm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/great-news-for-cnatm\/#primaryimage","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung.png","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2026\/03\/Posting_Weiterfoerderung.png","width":2053,"height":1746},{"@type":"WebSite","@id":"https:\/\/cnatm.de\/#website","url":"https:\/\/cnatm.de\/","name":"CNATM","description":"Cluster for Nucleic Acid Therapeutics Munich","publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnatm.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cnatm.de\/#organization","name":"CNATM","url":"https:\/\/cnatm.de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","width":2362,"height":479,"caption":"CNATM"},"image":{"@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e","name":"Patrizia Torelli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","caption":"Patrizia Torelli"}}]}},"_links":{"self":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/6306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/comments?post=6306"}],"version-history":[{"count":7,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/6306\/revisions"}],"predecessor-version":[{"id":6314,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/6306\/revisions\/6314"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media\/6307"}],"wp:attachment":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media?parent=6306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/categories?post=6306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/tags?post=6306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}